ZNTL - Zentalis Pharmaceuticals, Inc.
1.23
-0.020 -1.626%
Share volume: 752,022
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.25
-0.02
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-07-2024 | 08-09-2024 | 11-12-2024 | 03-26-2025 | |
| Total revenue | 40.560 M | 0.000 | 0.000 | 26.865 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 40.560 M | 0.000 | 0.000 | 26.865 M | |
| -100.00% | nan% | inf% | |||
| Operating expenses | 65.325 M | 65.148 M | 51.432 M | 72.978 M | |
| Selling general and admin | 15.740 M | 16.762 M | 14.608 M | 40.005 M | |
| Research and development | 49.585 M | 48.386 M | 36.824 M | 32.973 M | |
| Total expenses | 65.325 M | 65.148 M | 51.432 M | 76.714 M | |
| -0.27% | -21.05% | 49.16% | |||
| Operating income | -24.765 M | -65.148 M | -51.432 M | -49.849 M | |
| Ebit | 10.183 M | -88.011 M | -40.185 M | -47.677 M | |
| Pretax income | 10.183 M | -88.011 M | -40.185 M | -47.677 M | |
| -964.29% | -54.34% | 18.64% | |||
| Income tax | 143.000 K | 266.000 K | -27.000 K | -205.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 10.040 M | -88.277 M | -40.158 M | -47.472 M | |
| -979.25% | 54.51% | -18.21% |
